Last reviewed · How we verify
NCT05109377
Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment
NA trial testing Endocan in Erectile Dysfunction in 90 participants. Status unknown.
15 November 2021
Quick facts
| Lead sponsor | Ankara Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 90 |
| Start date | 24 June 2021 |
| Primary completion | 15 November 2021 |
| Estimated completion | 15 December 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
Conditions studied
- Erectile Dysfunction — all drugs for Erectile Dysfunction →
Sponsor
Ankara Training and Research Hospital
Who can join
Adults 18 to 65, male only, with Erectile Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05109377
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Erectile Dysfunction
Currently open trials in the same condition.
- NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
- NCT07366970 — Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D? · NA · recruiting
- NCT06960746 — Changing Lifestyle in OSA Males Who Suffer Metabolic Syndrome and Impotence: Is There a Response? · NA · recruiting
- NCT06872866 — The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under · Phase 1 · recruiting
- NCT06805513 — Actual Use Trial of Tadalafil 5 mg · Phase 3 · recruiting
Other Ankara Training and Research Hospital trials
Trials by the same sponsor.
- NCT07150455 — Evaluation of Myocardial Function by Global Longitudinal Strain (GLS) Measurement in 2D Echocardiography of Patients Wit · completed
- NCT07467421 — "Effectiveness of Physical Therapy Added to Transforaminal Injection in Lumbar Radicular Pain" · NA · completed
- NCT07143084 — Investigation of the Relationship Between Nutritional Status Assessment and Frailty in Critical Care Patients · enrolling by invitation
- NCT07310667 — Assessing the Relationship Between Frailty and Skeletal Muscle Thickness in Critically Ill Patients · enrolling by invitation
- NCT06946030 — Pseudoexfoliation and Carpal Tunnel Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05109377 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Training and Research Hospital
- Last refreshed: 5 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05109377.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing